Contact Information
Email
r****@versantventures.com
Unlock
Company Information
Company
Belharra Therapeutics
Total Funding
130000000.0
Technologies
Outlook
Greenhouse.io
Basis
Micro
Remote
Keywords
chemoproteomics
research
drug discovery
biotechnology research
binding pockets
protein targets
high-throughput screening
photoaffinity labeling
drug-like probes
undrugged proteome
medicinal chemistry
first-in-class medicine
bioinformatics
cellular context
reversible binding
non-covalent interactions
protein-protein interactions
allosteric sites
native cellular environment
immuno-oncology
collaborative drug development
disease targets
proteomics
small molecules
pharmaceutical partnerships
high-value drug targets
proteomic library
chemical biology
data-driven science
machine learning in drug design
therapeutic innovation
first-in-class therapeutics
druggable proteome
novel drug targets
biotech collaboration
pipeline development
molecular binding sites
therapeutic areas
partnership development
global health impact
translational medicine
research & development
pharmaceutical industry
cross-disciplinary research
optimizing drug candidates
clinical applications
target identification
biopharmaceuticals
therapeutic discovery
data integration
clinical research
transformative therapeutics
information technology & services
biotechnology
enterprise software
enterprises
computer software
b2b
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans